Lv1
30 积分 2025-06-27 加入
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9–Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment
13小时前
求助中
Pancreatic cancer
1天前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2个月前
已完结
Response to programmed cell death protein 1 antibody in patients with Epstein–Barr virus-associated intrahepatic cholangiocarcinoma
2个月前
已完结
Unravelling the complexities of resistance mechanism in pancreatic cancer: insights from in vitro and ex-vivo model systems
2个月前
已完结
An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer
2个月前
已完结
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
3个月前
已完结
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
3个月前
已关闭
Development and clinical application of bispecific antibody in the treatment of colorectal cancer
4个月前
已完结
Neoadjuvant cadonilimab plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma: A multicenter, phase 2 study
4个月前
已完结
皖公网安备34019202002308
